[HTML][HTML] Pharmaceuticals promoting premature termination codon readthrough: progress in development

S Li, J Li, W Shi, Z Nie, S Zhang, F Ma, J Hu, J Chen… - Biomolecules, 2023 - mdpi.com
Around 11% of all known gene lesions causing human genetic diseases are nonsense
mutations that introduce a premature stop codon (PTC) into the protein-coding gene …

2-Aminothiazole-4-carboxamides enhance readthrough of premature termination codons by aminoglycosides

SM Rabea, A Baradaran-Heravi, AD Balgi… - ACS Medicinal …, 2019 - ACS Publications
Nonsense mutations introduce a premature termination codon (PTC) and are the underlying
cause of multiple rare genetic diseases and cancers. Although certain aminoglycosides bind …

[HTML][HTML] Readthrough compounds for nonsense mutations: bridging the translational gap

S Spelier, EPM van Doorn, CK van der Ent… - Trends in molecular …, 2023 - cell.com
Approximately 10% of all pathological mutations are nonsense mutations that are
responsible for several severe genetic diseases for which no treatment regimens are …

Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs)

K Nagel-Wolfrum, F Möller, I Penner, T Baasov… - BioDrugs, 2016 - Springer
In recent years, remarkable advances in the ability to diagnose genetic disorders have been
made. The identification of disease-causing genes allows the development of gene-specific …

Sense from nonsense: therapies for premature stop codon diseases

L Bidou, V Allamand, JP Rousset, O Namy - Trends in molecular medicine, 2012 - cell.com
Ten percent of inherited diseases are caused by premature termination codon (PTC)
mutations that lead to degradation of the mRNA template and to the production of a non …

[HTML][HTML] Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons

M Dabrowski, Z Bukowy-Bieryllo, E Zietkiewicz - Molecular medicine, 2018 - Springer
Premature termination codons (PTCs) in the coding regions of mRNA lead to the incorrect
termination of translation and generation of non-functional, truncated proteins. Translational …

2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases

L Bidou, O Bugaud, G Merer… - Proceedings of the …, 2022 - National Acad Sciences
Premature termination codons (PTCs) account for 10 to 20% of genetic diseases in humans.
The gene inactivation resulting from PTCs can be counteracted by the use of drugs …

Nonaminoglycoside compounds induce readthrough of nonsense mutations

L Du, R Damoiseaux, S Nahas, K Gao, H Hu… - Journal of Experimental …, 2009 - rupress.org
Large numbers of genetic disorders are caused by nonsense mutations for which compound-
induced readthrough of premature termination codons (PTCs) might be exploited as a …

[HTML][HTML] Aminoglycosides and other factors promoting stop codon readthrough in human cells

D Diop, C Chauvin, O Jean-Jean - Comptes Rendus Biologies, 2007 - Elsevier
Enhanced stop codon readthrough is a potential treatment strategy for diseases caused by
nonsense mutations. Here, we compare readthrough levels induced by three types of …

[HTML][HTML] Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination …

R Perriera, E Vitale, I Pibiri, PS Carollo, D Ricci… - International Journal of …, 2023 - mdpi.com
Nonsense mutations cause several genetic diseases such as cystic fibrosis, Duchenne
muscular dystrophy, β-thalassemia, and Shwachman–Diamond syndrome. These mutations …